Positions 51–62 of 62.
Question in the title, detail here: someone explain satiety to me like I have not read a paper in years. Amylin is co-secreted with insulin and acts on satiety and…
the satiety question that gets asked weekly, answered properly, and I am aware this is a minority view on this board. Why this compound is not simply another agonist,…
Genuine question, and the title is the question: someone explain cagrilintide to me like I have not read a paper in years. Bought small deliberately because the…
reading cagrilintide threads from 2024 and half of it aged badly. Not a hot take, just something I have not seen said plainly here. Asked a question here that turned…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsweek 45 check-in — 21kg down, sulphur burps manageable, one thing confusing me. Numbers below. Ask me the boring questions, they are the useful ones. Figures up front…
Here it is: 23 months in and satiety is still the thing I get wrong. One person, one log, no control group, so read it accordingly. The numbers the title promised,…
Posting this as a discussion rather than a claim: amylin: what the trials say vs what this community says. Independent purity data on this compound is sparse compared…
am I the only one who found amylin harder than the injections, and I want the answer with the reasoning attached rather than just the conclusion. Combination and…
small win: cagrilintide stopped being a problem at week 75. Numbers below. Ask me the boring questions, they are the useful ones. Dosing intuitions from the GLP-1…
Six-word version is the title — week 68 check-in — 34kg down, nausea manageable, one thing confusing me — and the rest is context. week 68 and 34kg. Those are measured,…
Here it is: week 17 check-in — 4kg down, fatigue manageable, one thing confusing me. One person, one log, no control group, so read it accordingly. Hard numbers: week…
small win: cagrilintide stopped being a problem at week 60. Numbers below. Ask me the boring questions, they are the useful ones. Dosing intuitions from the GLP-1…
Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference